Department of Biology, Texas A&M University, College Station, USA.
Antimicrobial Division, Sano Chemicals Inc, Bryan, USA.
Expert Opin Drug Discov. 2021 Jul;16(7):807-822. doi: 10.1080/17460441.2021.1877655. Epub 2021 Jan 29.
: The increasing threat of antibiotic-resistant pathogens makes it imperative that new antibiotics to combat them are discovered. is a genus of Gram-negative, non-sporulating bacteria. While ubiquitous and capable of growing within plants and groundwater, they are primarily soil-dwelling organisms. These include the more virulent forms of such as , and the complex (Bcc).: This review provides a synopsis of current research on the natural products isolated from the genus . The authors also cover the research on the drug discovery efforts that have been performed on the natural products derived from .: Though has a small number of pathogenic species, the majority of the genus is avirulent and almost all members of the genus are capable of producing useful antimicrobial products that could potentially lead to the development of novel therapeutics against infectious diseases. The need for discovery of new antibiotics is urgent due to the ever-increasing prevalence of antibiotic-resistant pathogens, coupled with the decline in the discovery of new antibiotics.
: 抗生素耐药性病原体的威胁日益增加,因此必须发现新的抗生素来对抗它们。 是革兰氏阴性、非孢子形成细菌的一属。虽然它们无处不在,能够在植物和地下水中生长,但它们主要是土壤生物。其中包括更具毒性的形式,如 和 复合体(Bcc)。: 这篇综述提供了对从该属中分离出的天然产物的当前研究的概述。作者还介绍了对从 衍生的天然产物进行药物发现努力的研究。: 尽管 只有少数致病物种,但该属的大多数是无毒的,几乎所有该属的成员都能够产生有用的抗菌产品,这些产品有可能导致针对传染病的新型治疗方法的开发。由于抗生素耐药性病原体的患病率不断增加,加上新抗生素的发现减少,因此对发现新抗生素的需求非常迫切。